CELLULAR LONGEVITY, INC., DBA LOYAL
Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related diseases like cancer and dementia.
CELLULAR LONGEVITY, INC., DBA LOYAL
Industry:
Biotechnology Pet Veterinary
Founded:
2019-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.loyalfordogs.com
Status:
Active
Email Addresses:
[email protected]
Total Funding:
58 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Content Delivery Network
Similar Organizations
Axcella
Axcella is a biotechnology company that treats diseases using endogenous metabolic modulators.
Kindred Biosciences
Kindred Biosciences is a veterinary biotechnology company that focuses on developing therapies for dogs, cats and horses.
Current Employees Featured
Founder
Investors List
Ashley Mayer
Ashley Mayer investment in Series A - Cellular Longevity, Inc., dba Loyal
Claire Hughes Johnson
Claire Hughes Johnson investment in Series A - Cellular Longevity, Inc., dba Loyal
BoxGroup
BoxGroup investment in Series A - Cellular Longevity, Inc., dba Loyal
Khosla Ventures
Khosla Ventures investment in Series A - Cellular Longevity, Inc., dba Loyal
First Round Capital
First Round Capital investment in Series A - Cellular Longevity, Inc., dba Loyal
LGF
LGF investment in Series A - Cellular Longevity, Inc., dba Loyal
Quiet Capital
Quiet Capital investment in Series A - Cellular Longevity, Inc., dba Loyal
Brianne Kimmel
Brianne Kimmel investment in Series A - Cellular Longevity, Inc., dba Loyal
The Longevity Fund
The Longevity Fund investment in Series A - Cellular Longevity, Inc., dba Loyal
Collaborative Fund
Collaborative Fund investment in Series A - Cellular Longevity, Inc., dba Loyal
Official Site Inspections
http://www.loyalfordogs.com Semrush global rank: 2.44 M Semrush visits lastest month: 7.34 K
- Host name: ec2-54-200-253-157.us-west-2.compute.amazonaws.com
- IP address: 54.200.253.157
- Location: Boardman United States
- Latitude: 45.8491
- Longitude: -119.7143
- Metro Code: 810
- Timezone: America/Los_Angeles
- Postal: 97818
More informations about "Cellular Longevity, Inc., dba Loyal"
Helping dogs live longer, healthier lives | Loyal
Loyal is a clinical-stage veterinary medicine company working on giving dogs longer, healthier lives.See details»
Loyal - Crunchbase Company Profile & Funding
Contact Email [email protected] Loyal is a biotechnology company developing medicines to extend dog lifespan. By developing drugs with the potential to slow the aging process, they aim to delay or prevent age-related …See details»
Loyal - LinkedIn
Loyal is a clinical-stage veterinary medicine company developing drugs intended to extend the lifespan and healthspan of dogs. In other words, our mission is to help dogs live longer, healthier...See details»
Clinical trials | Loyal
At Loyal, we’re a clinical-stage veterinary medicine company developing drugs intended to extend the healthy lifespan of dogs. We’ve launched the STAY study — a double-blinded, placebo-controlled study recruiting 1,000 senior dogs in …See details»
FDA Center for Veterinary Medicine agrees Loyal’s data …
Nov 28, 2023 · Today, I’m so proud to announce that Loyal has earned what we believe to be the FDA’s first-ever formal acceptance that a drug can be developed and approved to extend lifespan. In regulatory parlance, we have completed …See details»
Morris Animal Foundation Partners with Loyal
DENVER/June 7, 2021 – In an effort to improve canine health and longevity, Morris Animal Foundation, a nonprofit leader in advancing animal health, is partnering with Loyal, a biotech …See details»
Recommended Stories - Yahoo Finance
SAN FRANCISCO, March 21, 2024 -- (BUSINESS WIRE)-- Loyal, a biotech company pioneering longevity drugs for dogs, today announced that it has successfully completed its Series B funding round,...See details»
Cellular Longevity Inc (dba Loyal) - VentureRadar
Website: https://loyalfordogs.com Develops drugs for dogs with the aim to extend their lifespan and maintain quality of life as they age. Currently has three drugs in development.See details»
Loyal Company Profile - Office Locations, Competitors, Revenue
Loyal (also known as Cellular Longevity) is a biotechnology company developing therapeutics aimed at extending both lifespan and healthspan for dogs. It utilizes companion dog citizen …See details»
Loyal Reaches FDA Milestone for its Drug to Extend …
Nov 28, 2023 · Loyal is a biotech startup developing the first drugs intended to help dogs live longer, healthier lives. By targeting the underlying mechani sms of aging, Loyal hopes to extend the lifespan of dogs and maintain their quality of …See details»
Loyal Launches Nationwide, 1,000-Dog Clinical Trial for …
SAN FRANCISCO, February 01, 2024 -- (BUSINESS WIRE)-- Loyal, a biotech company pioneering longevity drugs for dogs, announced today that it has dosed the first dog in its STAY study, the pivotal...See details»
Pawsitively Groundbreaking: Life-Extending Drug for Dogs Clears …
Dec 14, 2023 · Loyal, the San Franciso-based veterinary biotech firm, has achieved a significant milestone as its lifespan-extending drug (LOY-001) for large dogs moves closer to obtaining …See details»
Loyal - We’re thrilled to announce we’ve raised $27... - Facebook
We’re thrilled to announce we’ve raised $27 million in Series A funding at Loyal. We are developing drugs intended to extend dog lifespan and healthspan. See the TechCrunch article …See details»
FDA Agrees Loyal Data Supports Reasonable Expectation of …
SAN FRANCISCO, November 28, 2023 -- (BUSINESS WIRE)-- Loyal, a biotech company pioneering longevity drugs for dogs, announced today that the Food and Drug Administration …See details»
Loyal’s latest milestone: the first longevity clinical study design ...
Mar 10, 2023 · At Loyal we’re developing the first FDA-approved drugs explicitly intended to extend lifespan and healthspan, and being first means charting new waters.See details»
Chief of Staff - Celine Halioua
We’re developing drugs to extend dog lifespan; I want to build the defining aging company (“The SpaceX of aging”). In the last year, we’ve built the team from just me to 20+, from idea to …See details»
Loyal - Facebook
Helping dogs live longer, healthier lives.See details»
Loyal (@loyalfordogs) • Instagram photos and videos
2,962 Followers, 177 Following, 50 Posts - Loyal (@loyalfordogs) on Instagram: "Helping dogs live longer, healthier lives ? Join us in our mission to develop the first-ever canine longevity drugs."See details»
Meet Boo, the first dog dosed in our study - Loyal Blog
Feb 1, 2024 · Today, we’re announcing that we’ve dosed the first dog in our STAY study — our pivotal efficacy study to demonstrate lifespan extension in senior dogs treated with LOY-002.See details»
Loyal | Save the (senior) dogs, save the world! In ... - Instagram
Nov 1, 2024 · loyalfordogs Save the (senior) dogs, save the world! In celebration of November Senior Pet Month, we’re partnering with the Senior and Geriatric Dog Society @seniordogvets …See details»